Pharmacogenomic testing for warfarin dosing: we are ready now.
作者信息
Wu Alan H B
出版信息
Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1483-5. doi: 10.1586/erc.09.117.
PMID:19954308
Abstract
摘要
相似文献
1
Pharmacogenomic testing for warfarin dosing: we are ready now.
Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1483-5. doi: 10.1586/erc.09.117.
2
Warfarin and pharmacogenomic testing: what would Pascal do?
Pharmacotherapy. 2009 Mar;29(3):245-7. doi: 10.1592/phco.29.3.245.
3
Pathology consultation on warfarin pharmacogenetic testing.
Am J Clin Pathol. 2011 Jan;135(1):13-9. doi: 10.1309/AJCPAO82OTNPUBLW.
4
Genetic testing for warfarin dosing? Not yet ready for prime time.
Pharmacotherapy. 2008 Feb;28(2):141-3. doi: 10.1592/phco.28.2.141.
5
Refining the use of warfarin through genetic testing.
Int Angiol. 2008 Aug;27(4):271-3.
6
Warfarin pharmacogenetics: ready for clinical utility?
Clin Lab Sci. 2009 Summer;22(3):151-5.
7
Pharmacogenetic-based dosing of warfarin.
Med Lett Drugs Ther. 2008 May 19;50(1286):39-40.
8
Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.
Circulation. 2011 Dec 6;124(23):2554-9. doi: 10.1161/CIRCULATIONAHA.111.019737.
9
An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
Thromb Haemost. 2008 Aug;100(2):229-39.
10
The long and winding road to warfarin pharmacogenetic testing.
J Am Coll Cardiol. 2010 Jun 22;55(25):2813-5. doi: 10.1016/j.jacc.2010.04.006.
Zotero 插件